Stay updated on AK104 Plus Anlotinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104 Plus Anlotinib in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    There are no additions or deletions recorded for this study history in the provided data.
    Difference
    0.1%
    Check dated 2026-05-21T22:38:36.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.5.4' was added to the Record History, indicating the study record has been updated to a newer version in the history log.
    Difference
    0.2%
    Check dated 2026-05-14T22:17:04.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A new revision entry v3.5.3 was added to the Record History, and the previous revision v3.5.2 was removed.
    Difference
    0.1%
    Check dated 2026-04-30T15:37:10.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 was added to the version history, and the entry for v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:12:53.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The history now includes a new revision v3.5.0 and removes the previous revision v3.4.3 from the record history.
    Difference
    0.1%
    Check dated 2026-03-25T20:14:37.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The history shows a new release entry for v3.4.3 and removes the previous v3.4.2 entry.
    Difference
    0.1%
    Check dated 2026-03-11T14:24:32.000Z thumbnail image

Stay in the know with updates to AK104 Plus Anlotinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.